These findings suggest that extracellular free B2M potentially serves as a pro-inflammatory molecule in ischemic stroke by activating the NLRP3 inflammasome and promoting the release of inflammatory factors (Chen et al. 2023). This evidence concerns the gene NLRP3 and ischemic stroke.